Feedback / Questions
ANB033 - AnaptysBio
rosnilimab (ANB030) - AnaptysBio
ANB101 - AnaptysBio
https://www.globenewswire.com/news-release/2025/02/27/3034349/0/en/Anaptys-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html
Feb 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next